Section: Surgical Oncology Curriculum: Curriculum, page 70

General

  • Preferred treatment for many pts with end-stage renal disease
    • Provides better quality of life than dialysis
    • Releases pts from the dietary and fluid restrictions of dialysis and the physical constraints imposed by the need to dialyse
  • More cost-effective and probably improves survival
  • Frequently the primary cause of ESRF is unknown

Indications

(Causes of ESRF)

  • Glomerulonephritis
  • Diabetic nephropathy
  • Hypertensive nephrosclerosis
  • Renal vascular disease
  • Polycystic disease
  • Pyelonephritis
  • Obstructive uropathy
  • SLE
  • Analgesic nephropathy
  • Metabolic diseases
  • Oxalosis, Amyloid

Pre-Transplant Evaluation

  • All pts formally assessed by MDT team
    • Incl. transplant surgeon and nephrologist
  • Significant number are likely considered unsuitable because of major comorbidity, esp. cardiovascular disease
  • Nature of the 1° renal disease does not generally affect the decision to proceed to transplantation
  • No absolute upper age limit to transplantation
    • However, older patients (over the age of 65 years) are less likely to be considered because of major comorbidity
  • Cardiovascular assessment particularly important
    • Cardiovascular disease very common in dialysis population
      • Esp. those with diabetes
    • The major cause of death after transplantation
  • Ensure urinary tract is functional and that there is no need for corrective urological surgery
    • Only when there is intractable renal sepsis or very large polycystic kidneys that intrude into both iliac fossae is native nephrectomy required before transplantation
  • Make sure able to cope psychologically with transplantation and likely to comply with immunosuppressive therapy
  • Contraindications:
    • Pre-existing malignancy (wait 3yr till after treatment)
    • Active infection

Technique of renal transplant

  • Placed in the iliac fossa in the experitoneal position
    • Leaving the native kidneys in-situ
  • Vascular
    • Donor Renal Vein is anastomosed end-to-side to the External Iliac Vein
    • If from deceased donor, Renal Artery will come with Carrel Patch
      • Patch of Aorta that gives rise to Renal Artery/arteries
      • Anastomosed end-to-side to the External Iliac Artery
    • If the donor renal artery lacks an aortic patch, (living donor transplant)
      • Anastomose the donor artery end-to-end to the recipient Internal Iliac Artery
    • Following completion of the venous and arterial anastomoses, the vascular clamps are removed and the kidney is allowed to reperfuse with blood
  • Ureter
    • Kept reasonably short to avoid the risk of distal ischaemia
    • Direct implantation of the ureter into the dome of the bladder
    • Mucosa-to-mucosa anastomosis
    • Followed by closure of the muscular wall of the bladder over the ureter to create a short tunnel
    • JJ ureteric stent left in-situ
      • Reduce the risk of urine leak or early obstruction
    • Before closing, important to check is in satisfactory position
    • Without kinking/torsion

Technical Complications

Vascular

  • Incidence of vascular complications low
  • Renal Artery Thrombosis (1%)
  • Renal Vein Thrombosis is more common (up to 5% of cases)
    • Aetiology often uncertain
      • Sometimes from technical error
    • Presents during the 1st week
      • Sudden pain and swelling at the site of the graft
    • Diagnosis confirmed by Doppler USS
    • Urgent surgical exploration indicated
      • In most cases, transplant nephrectomy is required
    • Can be minimised by giving low-dose heparin or aspirin prophylaxis
  • Renal Artery Stenosis (up to 10%)
    • Usually presents late (often years)
    • Get increasing hypertension and decreasing renal function
    • Diagnosed by angiography
    • Best treated by angioplasty
      • If unsuccessful or not technically possible, may need open surgery and vascular reconstruction

Urological

  • Urological complications ~ 5% in the early post-transplant period
    • Incidence can be reduced markedly by leaving temporary ureteric stent
  • Urinary leaks
    • Result from technical errors at the ureteric anastomosis or ureteric ischaemia
    • Present with discomfort and leakage of urine from the wound
    • Usually require surgical intervention
      • Reimplantation of the ureter into the bladder
      • Or anastomosis of the transplant ureter to the ipsilateral native ureter
  • Obstruction of the transplant ureter
    • May occur early or late
    • Causes:
      • Technical error
      • External pressure from a haematoma or lymphocele
      • Ischaemic stricture
    • Presents with painless deterioration of graft function
    • Diagnosed on USS
      • Hydronephrosis and ureteric dilatation
    • Initial treatment is by percutaneous antegrade nephrostomy
      • And sometimes insertion of a stent
    • Some amenable to balloon dilatation
    • Most are best treated by surgical intervention

Lymphocoele

  • Usually asymptomatic
  • Occasionally large enough to cause ureteric obstruction or oedema of the ipsilateral leg
  • Initial treatment
    • Ultrasound-guided percutaneous drainage
  • In large or recurrent lymphoceles
    • Repeated instillation of povidone-iodine into the lymphocele cavity by a percutaneous drain
  • Surgical intervention may be needed to drain a persistent lymphocele into the peritoneal cavity

Renal Transplant Consent

  • Complications
    • Whitebook, page 122

Causes of Graft Dysfunction

Investigation of Graft Dysfunction

  • Delayed Graft Function
    • Definition: Need for dialysis post- transplantation as a result of acute tubular necrosis
  • Incidence:
    • 30% of heart-beating deceased donors
    • Up to 50% of NHBD kidney transplants
    • Uncommon (< 5%) following living donor transplantation
  • Oliguria may be useless indicator as recipients may produce significant urine from their native kidneys
  • Delayed function minimised by:
    • Optimizing donor management before kidney procurement
    • Reducing the cold ischaemia time
  • Management of Early Graft Dysfunction
    • First step - urinary catheter should be irrigated in case it is occluded by a blood clot
    • Hypovolaemia fixed and CVP monitors
    • Calcineurin inhibitors often withheld/reduced
  • Investigations
    • Doppler USS of graft is single most important investigation
      • Allows exclusion of vascular thrombus and urinary obstruction as causes
    • Radionucleotide scan may give information of perfusion and excretion
    • If dysfunction still present after a few days
      • USS-guided biopsy
    • ATN usually resolves within 4 weeks
    • < 5% suffer primary non-function and never regain function

Outcome After Transplant